search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Chromatography 23


Manufacturer-Packed HPLC Columns for Every Application MACHEREY-NAGEL, a pioneer in chromatography, introduced its NUCLEOSIL®


NUCLEOSIL® silica was originally developed by them in Germany. The manufacturer-packed NUCLEOSIL® columns packed with a superficially porous silica for highest efficiency in HPLC. silica provide phases for many individual applications. , C6 H5 ,CN, NH2


HPLC columns into the market more than 40 years ago. The spherical columns are now exclusively offered by


MACHEREY-NAGEL and authorised distributors. For nearly 15 years, they have supplemented their successful NUCLEOSIL® packed with the fully synthetical silica NUCLEODUR® NUCLEOSHELL®


NUCLEOSIL®


because the silica is robust. Numerous different modifications (e.g., C18 120, 300, 500, 1000, 4000 Å) of NUCLEOSIL®


column range by columns – a state-of-the-art silica for professional solutions. A few years ago, MACHEREY-NAGEL introduced


columns – until now also packed by other column manufacturers – are often used in quality control around the globe for validated methods , C8


Further information can be found on www.mn-net.com/NUCLEOSIL For daily routine analysis as well as for sophisticated analytical separations, NUCLEODUR®


for separations of basic and acidic analytes with high peak symmetry. They are also ideal for method development, LC-MS detection and UHPLC. Further selectivities are provided with CN/CN-RP and NH2


are recommended. Several different surface modifications have been developed over the last years providing a full range of specified HPLC phases. Surface deactivated phases like C8


and C18 for low molecular analytes – C18 ec and C4 ec with 300 Å for proteins and peptides. NUCLEODUR®


Gravity, C18 /NH2


Gravity-SB, C18 -RP phases. C18


ec and C8 Isis, C18


More information on www.mn-net.com/NUCLEODUR Core-shell technology sets new standards for analyses in research and quality control. NUCLEOSHELL®


C18 More information on www.mn-net.com/NUCLEOSHELL


Decades of experience in phase development, sorbent manufacturing and column packing by MACHEREY-NAGEL obtain safe and reliable results in HPLC. A wide variety of applications are provided in their free-of-charge application database www.mn-net.com/apps


39774pr@reply-direct.com


Pyramid, PolarTec, Phenyl-Hexyl, Sphinx RP, PFP and HILIC are well-suitable ec modifications with a pore size of 110 Å are modern standard phases


HTec is the preferred phase for preparative HPLC. columns fulfill the demands for HPLC separations


with respect to separation efficiency, detection limits, and time requirements for each analysis. MACHEREY-NAGEL offers the core-shell phases RP 18, RP 18plus, Phenyl-Hexyl, PFP, and HILIC with the highly efficient particle size of 2.7 µm. Especially for an allowed transfer of Pharmacopoeia methods, the important modifications NUCLEOSHELL®


RP 18 and more polar RP 18plus are also available with the particle size of 5 µm. columns manufacturer-packed with high pressure stable silica , SA, SB), particle sizes (3, 5, 7, 10 µm) and pore sizes (50, 100,


5438ad@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132